General description
Medicine type
Chemical agent
EML status history
First added in 2019
(TRS
1021)
for
Acute myeloid leukaemia with recurrent genetic abnormalities
Wikipedia
Recommendations
Section
Cytotoxic medicines
- Oral > Solid: 270 mg (containing tetra-arsenic tetra-sulfide 30 mg)